1250 related articles for article (PubMed ID: 15326102)
41. Plasminogen kringle 5 inhibits alkali-burn-induced corneal neovascularization.
Zhang Z; Ma JX; Gao G; Li C; Luo L; Zhang M; Yang W; Jiang A; Kuang W; Xu L; Chen J; Liu Z
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4062-71. PubMed ID: 16249481
[TBL] [Abstract][Full Text] [Related]
42. Inhibitory effects of the platelet-activating factor receptor antagonists, CV-3988 and Ginkgolide B, on alkali burn-induced corneal neovascularization.
Lee CM; Jung WK; Na G; Lee DS; Park SG; Seo SK; Yang JW; Yea SS; Lee YM; Park WS; Choi IW
Cutan Ocul Toxicol; 2015 Mar; 34(1):53-60. PubMed ID: 24754407
[TBL] [Abstract][Full Text] [Related]
43. VEGF189 stimulates endothelial cells proliferation and migration in vitro and up-regulates the expression of Flk-1/KDR mRNA.
Hervé MA; Buteau-Lozano H; Mourah S; Calvo F; Perrot-Applanat M
Exp Cell Res; 2005 Sep; 309(1):24-31. PubMed ID: 15996656
[TBL] [Abstract][Full Text] [Related]
44. The proangiogenic phenotype of tumor-derived endothelial cells is reverted by the overexpression of platelet-activating factor acetylhydrolase.
Doublier S; Ceretto M; Lupia E; Bravo S; Bussolati B; Camussi G
Clin Cancer Res; 2007 Oct; 13(19):5710-8. PubMed ID: 17908960
[TBL] [Abstract][Full Text] [Related]
45. Early growth response-1 regulates angiopoietin-1-induced endothelial cell proliferation, migration, and differentiation.
Abdel-Malak NA; Mofarrahi M; Mayaki D; Khachigian LM; Hussain SN
Arterioscler Thromb Vasc Biol; 2009 Feb; 29(2):209-16. PubMed ID: 19112164
[TBL] [Abstract][Full Text] [Related]
46. VEGF-A and FGF-2 synergistically promote neoangiogenesis through enhancement of endogenous PDGF-B-PDGFRbeta signaling.
Kano MR; Morishita Y; Iwata C; Iwasaka S; Watabe T; Ouchi Y; Miyazono K; Miyazawa K
J Cell Sci; 2005 Aug; 118(Pt 16):3759-68. PubMed ID: 16105884
[TBL] [Abstract][Full Text] [Related]
47. Role of the low-affinity leukotriene B4 receptor BLT2 in VEGF-induced angiogenesis.
Kim GY; Lee JW; Cho SH; Seo JM; Kim JH
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):915-20. PubMed ID: 19286633
[TBL] [Abstract][Full Text] [Related]
48. Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator.
Liu L; Zuurbier AE; Mul FP; Verhoeven AJ; Lutter R; Knol EF; Roos D
J Immunol; 1998 Sep; 161(6):3064-70. PubMed ID: 9743372
[TBL] [Abstract][Full Text] [Related]
49. Endothelial cell response to lactate: implication of PAR modification of VEGF.
Kumar VB; Viji RI; Kiran MS; Sudhakaran PR
J Cell Physiol; 2007 May; 211(2):477-85. PubMed ID: 17167776
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of corneal angiogenesis by local application of vasostatin.
Wu PC; Yang LC; Kuo HK; Huang CC; Tsai CL; Lin PR; Wu PC; Shin SJ; Tai MH
Mol Vis; 2005 Jan; 11():28-35. PubMed ID: 15660022
[TBL] [Abstract][Full Text] [Related]
51. [Angiogenic effect of interleukin-8 in breast cancer and its association with estrogen receptor].
Lin Y; Wang SM; Huang RP
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(20):1419-23. PubMed ID: 16029657
[TBL] [Abstract][Full Text] [Related]
52. Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth.
Fahmy RG; Dass CR; Sun LQ; Chesterman CN; Khachigian LM
Nat Med; 2003 Aug; 9(8):1026-32. PubMed ID: 12872165
[TBL] [Abstract][Full Text] [Related]
53. Doxazosin inhibits human vascular endothelial cell adhesion, migration, and invasion.
Keledjian K; Garrison JB; Kyprianou N
J Cell Biochem; 2005 Feb; 94(2):374-88. PubMed ID: 15526277
[TBL] [Abstract][Full Text] [Related]
54. Effect of FGF-1 and FGF-2 on VEGF binding to human umbilical vein endothelial cells.
Chen JH; Wang XC; Kan M; Sato JD
Cell Biol Int; 2001; 25(3):257-60. PubMed ID: 11352499
[TBL] [Abstract][Full Text] [Related]
55. Receptor-mediated and protein kinase-dependent growth enhancement of primary human fibroblasts by platelet activating factor.
Bennett SA; Birnboim HC
Mol Carcinog; 1997 Dec; 20(4):366-75. PubMed ID: 9433481
[TBL] [Abstract][Full Text] [Related]
56. Fibroblast growth factor-2, but not vascular endothelial growth factor, upregulates telomerase activity in human endothelial cells.
Kurz DJ; Hong Y; Trivier E; Huang HL; Decary S; Zang GH; Lüscher TF; Erusalimsky JD
Arterioscler Thromb Vasc Biol; 2003 May; 23(5):748-54. PubMed ID: 12676798
[TBL] [Abstract][Full Text] [Related]
57. Nitric oxide mediates angiogenesis induced in vivo by platelet-activating factor and tumor necrosis factor-alpha.
Montrucchio G; Lupia E; de Martino A; Battaglia E; Arese M; Tizzani A; Bussolino F; Camussi G
Am J Pathol; 1997 Aug; 151(2):557-63. PubMed ID: 9250168
[TBL] [Abstract][Full Text] [Related]
58. Insulin-like growth factor binding protein-7 (IGFBP7) blocks vascular endothelial cell growth factor (VEGF)-induced angiogenesis in human vascular endothelial cells.
Tamura K; Hashimoto K; Suzuki K; Yoshie M; Kutsukake M; Sakurai T
Eur J Pharmacol; 2009 May; 610(1-3):61-7. PubMed ID: 19374835
[TBL] [Abstract][Full Text] [Related]
59. Relative effects of VEGF-A and VEGF-C on endothelial cell proliferation, migration and PAF synthesis: Role of neuropilin-1.
Bernatchez PN; Rollin S; Soker S; Sirois MG
J Cell Biochem; 2002; 85(3):629-39. PubMed ID: 11968003
[TBL] [Abstract][Full Text] [Related]
60. Glucagon like peptide-2 induces intestinal restitution through VEGF release from subepithelial myofibroblasts.
Bulut K; Pennartz C; Felderbauer P; Meier JJ; Banasch M; Bulut D; Schmitz F; Schmidt WE; Hoffmann P
Eur J Pharmacol; 2008 Jan; 578(2-3):279-85. PubMed ID: 17920582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]